Effects of interferon-α and γ on development of LAK activity from mononuclear cells in breast cancer patients

Journal of Medical Investigation

Volumn 45, Issue 1-2, 1998, Pages 71-75

  Kamamura, Yoshitaka ^a   Takahashi, Keiji ^a   Komaki, Kansei ^a   Monden, Yasumasa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Breast cancer; IFN ; IFN ; IL 2; LAK

Indexed keywords

ALPHA INTERFERON; ESTROGEN; GAMMA INTERFERON; INTERLEUKIN 2; RECOMBINANT PROTEIN;

ARTICLE; BREAST TUMOR; BURKITT LYMPHOMA; CYTOLOGY; CYTOTOXICITY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; NEOPLASM; PATHOLOGY;

BREAST NEOPLASMS; BURKITT LYMPHOMA; CYTOTOXICITY, IMMUNOLOGIC; ESTROGENS; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LEUKOCYTES, MONONUCLEAR; NEOPLASMS, HORMONE-DEPENDENT; RECOMBINANT PROTEINS;

EID: 0032130832     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Tran R, Horan HP, Greiner JW, Pestka S, Schlom J : Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons. J Interferon Res 8 : 75-88, 1988
2. Webb DS, Mostowski HS, Gerrard TL: Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol146 : 3682-3686, 1991
3. Aversa GG, Hall BM Cell surface markers of T-cell activation. Transplant Rev 5 : 9-30, 1991
4. Makgoba MW, Sanders ME, Shaw S: The CD 2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. Immunol Today 10: 417-422, 1989
5. Buckle AM, Hogg N : Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-γ. Eur J Immnol 20 : 337-341, 1990
6. Griffiths CEM, Voorhees JJ, Nickoloff BJ : Charac-terization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin : modulation by recombinant γ interferon and tumor necrosis factor. J Am Acad Dermatol 20 : 617-629, 1989
7. Prober JS : Cytokine-mediated activation of vascular endothelium. Am J Pathl 133 : 426-433, 1988
8. Ozzello L, Habif DV, DeRosa CM, Cantell K : Treatment of human breast cancer xenografts using natural interferons-α and-γ injected singly or in combination. J Interferon Res 8 : 679-690, 1988
9. Schiller JH, Grovenman DS, Schmid SM, Willson JKV, Cummings KB, Borden EC : Synergistic antiproliferative effects of human recombinant α 54- or βser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res 46 : 483-488, 1986
10. Ozzello L, Habif DV, DeRosa CM : Antiproliferative effects of natural interferon β alone and in combination with natural interferon γ on human breast carcinomas in nude mice. Breast Cancer Res Treat 16 : 89-96, 1990
11. Itoh K, Shiba K, Shimizu Y, Suzuki R, Kumagai K : Generation of activated killer (AK) cells by recombinant interleukin-2 (IL-2) in collaboration with interferon-γ (IFN-γ). J Immunol 134 : 3124-3129, 1985
12. Brunda M, Tarnowsky D. Davatelis V : Interaction of recombinant interferons with interleukin-2 : differential effects of natural killer cells. Int J Cancer 37 : 787-793, 1986
13. Ochoa A, Gromo G, Barbara BJ, Sondel PM, Bach FH : Long term growth of lymphokine-activated killer (LAK) cells : role of anti-CD 3, β-IL-1, interferon-γ and β. J Immunol 138 : 2728-2733, 1987
14. Sone S, Utsugi T, Nii A, Ogura T : Differential effects of recombinant interferon α, β, and γ on the induction of human lymphokine (IL-2)-activated killer activity. J Nat Cancer Inst 80 : 425-431, 1988
15. Weiss GR, Margolin KA, Aronson FR, Sznol M, Atkins MB, Ducher JP, Gaynor ER, Boldt DH, Doroshow JH, Bar MH, Hawkins MJ, Demchak PA, Gucalp R, Fisher R : A randomized phase II trial of continuous infusion interleukin-2or bolus injection interleukin-2plus lymphokine-activated killer cells for advanced renal cell carcinoma. J Clin Oncol 10 : 257-281, 1992
16. Ikarashi H, Fujita K, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K: Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Cancer Res 54 : 190-196, 1994
17. Kato K, Yamada T, Kawahara K, Onda H, Asano T, Sagino H : Purification and characterization recombinant human interleukin-2 produced in Escherichia coli. Biophys Res 31 : 692-699, 1985
18. Takahashi K, Sone S, Kimura S, Ogura T, Monden Y : Phenotypes and lymphokine activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 103 : 1732-1738, 1993
19. Takahashi K, Sone S, Saito S, Kamamura Y, Uyama T, Ogura T, Monden Y : Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion. Jpn J Cancer Res 86 : 861-866, 1995
20. Rosenberg SA, Spiess P, Lafreniere R : A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233 : 1318-1321, 1986
21. Takahashi K, Monden Y, Saito S, Kamamura Y, Uyama T : Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma. J Clin Immunol 16 : 190-197, 1996
22. Baxevanis CN, Dedoussis GVZ, Papadopoulos GP, Papamichail M : Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 74 : 1275-1282, 1994
23. Yoshimoto M, Sakamoto G, Ohashi Y : Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 72 : 2993-3001, 1993
24. Papamichail M, Baxevanis CN : γ-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes. J Chemother 4 : 387-393, 1992
25. Watanabe Y, Hashizume Y, Shimizu J, Yoshida M, Watanabe S, Iwa T, Sakai S, Migita S, Sato H, Murayama T, Koshimura S, Saito M : Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer. Am Rev Respir Dis 142 : 769-774, 1990
26. Solary E, Pud' homme JF, Gauville C : Moduration of proliferation, estradiol receptors and estrogen regulated protein PS 2/BCEI in human breast cancer cell lines by gamma interferon. J Biol Regul Homeost Agents 5 : 98-106, 1991
27. Wolf GT, Hudson JL, Peterson KA, Miller HL, McClatchey KD : Lymphocyte subpopulations infiltrating squamous carcinomas of head and neck : Correlation with extent of tumor and prognosis. Otolaryngol Head Neck Surg 95 : 142-152, 1986
28. Ferradini L, Miescher S, Stoeck M, Busson P, Cerf-Bensussan N, Lipinskim M, von-Fleidner V, Tursz T : Cytotoxic potential despite impaired activation pathway in T lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer 47 : 362-370, 1991
29. Black MM, Speer FD, Opler SR : Structural representations of tumor-host relationships in mammary carcinoma : biologic and prognostic significance. Am J Clin Pathol 26 : 250-65, 1956
30. Black MM, Barclay THC, Hankey BF : Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 36 : 2048-2055, 1975
31. Tiwari RK, Wong GY, Mukhopadhyay B, Telang NT, Liu J, Hakes TB, Osborne MP : IFN-α and γ mediated gene response in human breast carcinoma cell line. Br Cancer Res Treat 18 : 33-41, 1991
32. Iacobelli S, Natoli C, Arno E, Sbarigia G, Gaggini C : An estrogenic action of interferons in human breast cancer cells. Anticancer Res 6 : 1391-1394, 1986
33. Taylor-Papadimitrou J, Shearer M, Balkwill FR, Fantes KH : Effects of HuIFN-α (Namalwa) on breast cancer cells growth in culture and as xenografts in the nude mouse. J Interferon Res 2 : 479-491, 1982
34. Balkwill FR, Moodie EM, Freedman V, Fantes KH : Human interferon inhibits the growth of established human breast tumors on the nude mouse. Int J Cancer 22 : 231-235, 1982